SEARCH

SEARCH BY CITATION

References

  • 1
    Albrektsen G,Heuch I,Hansen S,Kvale G. Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects. Br J Cancer 2005; 92: 16775.
  • 2
    Albrektsen G,Heuch I,Tretli S,Kvale G. Breast cancer incidence before age 55 in relation to parity and age at first and last births: a prospective study of one million Norwegian women. Epidemiology 1994; 5: 60411.
  • 3
    Wohlfahrt J,Andersen PK,Mouridsen HT,Melbye M. Risk of late-stage breast cancer after a childbirth. Am J Epidemiol 2001; 153: 107984.
  • 4
    Britt K,Ashworth A,Smalley M. Pregnancy and the risk of breast cancer. Endocr Relat Cancer 2007; 14: 90733.
  • 5
    Hinkula M,Pukkala E,Kyyronen P,Kauppila A. Grand multiparity and the risk of breast cancer: population-based study in Finland. Cancer Causes Control 2001; 12: 491500.
  • 6
    Butt S,Borgquist S,Garne JP,Landberg G,Tengrup I,Olsson A,Manjer J. Parity in relation to survival following breast cancer. Eur J Surg Oncol 2009; 35: 7028.
  • 7
    Kroman N,Wohlfahrt J,Andersen KW,Mouridsen HT,Westergaard T,Melbye M. Parity, age at first childbirth and the prognosis of primary breast cancer. Br J Cancer 1998; 78: 152933.
  • 8
    Manjer J,Carlsson S,Elmstahl S,Gullberg B,Janzon L,Lindstrom M,Mattisson I,Berglund G. The Malmo Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants. Eur J Cancer Prev 2001; 10: 48999.
  • 9
    Manjer J,Elmstahl S,Janzon L,Berglund G. Invitation to a population-based cohort study: differences between subjects recruited using various strategies. Scand J Public Health 2002; 30: 10312.
  • 10
    Elston CW,Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19: 40310.
  • 11
    Borgquist S,Anagnostaki L,Jirstrom K,Landberg G,Manjer J. Breast tumours following combined hormone replacement therapy express favourable prognostic factors. Int J Cancer 2007; 120: 22027.
  • 12
    Borgquist S,Wirfalt E,Jirstrom K,Anagnostaki L,Gullberg B,Berglund G,Manjer J,Landberg G. Diet and body constitution in relation to subgroups of breast cancer defined by tumour grade, proliferation and key cell cycle regulators. Breast Cancer Res 2007; 9: R11.
  • 13
    Dowsett M,Bartlett J,Ellis IO,Salter J,Hills M,Mallon E,Watters AD,Cooke T,Paish C,Wencyk PM,Pinder SE. Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centres. J Pathol 2003; 199: 41823.
  • 14
    Brittain AW. Can women remember how many children they have borne? Data from the east. Caribbean Soc Biol 1991; 38: 21932.
  • 15
    Garne JP. Invasive breast cancer in Malmö 1961–1992—an epidemiological study. Dissertation, Lund University, Malmö 1996.
  • 16
    Lash TL,Fink AK. Null association between pregnancy termination and breast cancer in a registry-based study of parous women. Int JCancer 2004; 110: 4438.
  • 17
    Michels KB,Xue F,Colditz GA,Willett WC. Induced and spontaneous abortion and incidence of breast cancer among young women: a prospective cohort study. Arch Intern Med 2007; 167: 81420.
  • 18
    Trivers KF,Gammon MD,Abrahamson PE,Lund MJ,Flagg EW,Kaufman JS,Moorman PG,Cai J,Olshan AF,Porter PL,Brinton LA,Eley JW, et al. Association between reproductive factors and breast cancer survival in younger women. Breast Cancer Res Treat 2007; 103: 93102.
  • 19
    Hoos A,Cordon-Cardo C. Tissue microarray profiling of cancer specimens and cell lines: opportunities and limitations. Lab Invest 2001; 81: 13318.
  • 20
    Camp RL,Charette LA,Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest 2000; 80: 19439.
  • 21
    Clavel-Chapelon F. Cumulative number of menstrual cycles and breast cancer risk: results from the E3N cohort study of French women. Cancer Causes Control 2002; 13: 8318.
  • 22
    Daling JR,Malone KE,Doody DR,Anderson BO,Porter PL. The relation of reproductive factors to mortality from breast cancer. Cancer Epidemiol Biomarkers Prev 2002; 11: 23541.
  • 23
    Ma H,Bernstein L,Pike MC,Ursin G. Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res 2006; 8: R43.
  • 24
    Ursin G,Bernstein L,Lord SJ,Karim R,Deapen D,Press MF,Daling JR,Norman SA,Liff JM,Marchbanks PA,Folger SG,Simon MS, et al. Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. Br J Cancer 2005; 93: 36471.
  • 25
    Albrektsen G,Heuch I,Thoresen S,Kvale G. Clinical stage of breast cancer by parity, age at birth, and time since birth: a progressive effect of pregnancy hormones? Cancer Epidemiol Biomarkers Prev 2006; 15: 659.
  • 26
    Albrektsen G,Heuch I,Thoresen S,Kvale G. Family history of breast cancer and short-term effects of childbirths on breast cancer risk. Int J Cancer 2006; 119: 146874.
  • 27
    Hsieh CC,Chan HW,Lambe M,Ekbom A,Adami HO,Trichopoulos D. Does age at the last birth affect breast cancer risk? Eur J Cancer 1996; 32A: 11821.
  • 28
    Rosenberg LU,Einarsdottir K,Friman EI,Wedren S,Dickman PW,Hall P,Magnusson C. Risk factors for hormone receptor-defined breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2006; 15: 24828.
  • 29
    Kaplan HG,Malmgren JA. Impact of triple negative phenotype on breast cancer prognosis. Breast J 2008; 14: 45663.
  • 30
    Reis-Filho JS,Tutt AN. Triple negative tumours: a critical review. Histopathology 2008; 52: 10818.
  • 31
    Lagerlund M,Maxwell AE,Bastani R,Thurfjell E,Ekbom A,Lambe M. Sociodemographic predictors of non-attendance at invitational mammography screening—a population-based register study (Sweden). Cancer Causes Control 2002; 13: 7382.
  • 32
    Russo J,Moral R,Balogh GA,Mailo D,Russo IH. The protective role of pregnancy in breast cancer. Breast Cancer Res 2005; 7: 13142.
  • 33
    Kroman N,Wohlfahrt J,Andersen KW,Mouridsen HT,Westergaard T,Melbye M. Time since childbirth and prognosis in primary breast cancer: population based study. BMJ 1997; 315: 8515.
  • 34
    Russo J,Reina D,Frederick J,Russo IH. Expression of phenotypical changes by human breast epithelial cells treated with carcinogens in vitro. Cancer Res 1988; 48: 283757.
  • 35
    Russo J,Balogh GA,Russo IH. Full-term pregnancy induces a specific genomic signature in the human breast. Cancer Epidemiol Biomarkers Prev 2008; 17: 5166.
  • 36
    D'Cruz CM,Moody SE,Master SR,Hartman JL,Keiper EA,Imielinski MB,Cox JD,Wang JY,Ha SI,Keister BA,Chodosh LA. Persistent parity-induced changes in growth factors. TGF-beta3, and differentiation in the rodent mammary gland. Mol Endocrinol 2002; 16: 203451.